Trastuzumab deruxtecan related interstitial lung disease

Last revised by Yuranga Weerakkody on 21 Dec 2023

Citation, DOI, disclosures and article data

Citation:

Weerakkody Y, Trastuzumab deruxtecan related interstitial lung disease. Reference article, Radiopaedia.org (Accessed on 30 Apr 2024) https://doi.org/10.53347/rID-180845

DOI:

https://doi.org/10.53347/rID-180845

Permalink:

https://radiopaedia.org/articles/180845

rID:

180845

Article created:

20 Dec 2023, Yuranga Weerakkody ◉

Disclosures:

At the time the article was created Yuranga Weerakkody had no financial relationships to ineligible companies to disclose.

View Yuranga Weerakkody's current disclosures

Last revised:

21 Dec 2023, Yuranga Weerakkody ◉

Disclosures:

At the time the article was last revised Yuranga Weerakkody had no financial relationships to ineligible companies to disclose.

View Yuranga Weerakkody's current disclosures

Revisions:

2 times, by 1 contributor - see full revision history and disclosures

Systems:

Chest

Synonyms:

T-Dxd related interstitial lung disease
T-Dxd related ILD

Trastuzumab deruxtecan related interstitial lung disease (T-Dxd ILD) is a form of drug induced lung disease which can rarely occur with the antibody-drug conjugate trastuzumab deruxtecan (T-DXd).

It can cause a fatal pneumonitis and therefore its recognition is important.